OPALIA PHARMA, a subsidiary of the international group RECORDATI, is a Tunisian pharmaceutical company that has been committed for 35 years to innovation and health in Africa and the MENA region, ensuring access to quality medicines to meet patient needs and strengthen public health.
Image: Founder and CEO of Opalia Recordati, Dr. Alya El Hedda.
At Opalia Recordati, we are committed to improving the health and quality of life of patients by ensuring accessible, high-quality treatments that comply with the strictest international standards. With our expertise and dedication to innovation, we place ethics, integrity, and social and societal responsibility at the heart of our actions.
As a key player in the pharmaceutical sector, we foster a collaborative and dynamic environment where every talent can thrive and unleash its full potential.
We are committed to being socially and environmentally responsible throughout all our activities
Global Operations
Recordati is a global pharmaceutical company, listed on the Italian stock exchange, with more than 4,450 employees. We develop and market medicines to serve people with common diseases, as well as those living with some of the rarest diseases, in around 150 countries.